CY1105240T1 - 5’ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ - Google Patents

5’ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ

Info

Publication number
CY1105240T1
CY1105240T1 CY20061101369T CY061101369T CY1105240T1 CY 1105240 T1 CY1105240 T1 CY 1105240T1 CY 20061101369 T CY20061101369 T CY 20061101369T CY 061101369 T CY061101369 T CY 061101369T CY 1105240 T1 CY1105240 T1 CY 1105240T1
Authority
CY
Cyprus
Prior art keywords
ests
secretory proteins
different tissues
proteins expressed
sequences
Prior art date
Application number
CY20061101369T
Other languages
English (en)
Inventor
Jean-Baptiste Dumas Milne Edwards
Aymeric Duclert
Bruno Lacroix
Original Assignee
Serono Genetics Institute S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Institute S.A. filed Critical Serono Genetics Institute S.A.
Publication of CY1105240T1 publication Critical patent/CY1105240T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Abstract

Οι αλληλουχίες των 5' ESTs που προέρχονται από mRNAs που κωδικοποιούν εκκριτικές πρωτεΐνες εσωκλείονται. Τα 5' ESTs μπορεί να χρησιμοποιηθούν για να αποκτηθούν cDNAs και γονιδιωματικά DNAs που αντιστοιχούν στα 5' ESTs. Τα 5' ESTs μπορούν επίσης να χρησιμοποιηθούν σε διαγνωστικές, δικαστικές, γονιδιακής θεραπείας και διαδικασίες χρωμοσωμικής χαρτογράφησης. Ανάντη ρυθμιστικές αλληλουχίες μπορούν επίσης να αποκτηθούν χρησιμοποιώντας τα 5' ESTs. Τα 5' ESTs μπορούν επίσης να χρησιμοποιηθούν για τον σχεδιασμό φορέων έκφρασης και φορέων έκκρισης.
CY20061101369T 1997-08-01 2006-09-21 5’ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ CY1105240T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90505197A 1997-08-01 1997-08-01
EP98936595A EP1000151B1 (en) 1997-08-01 1998-07-31 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES

Publications (1)

Publication Number Publication Date
CY1105240T1 true CY1105240T1 (el) 2010-03-03

Family

ID=25420220

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20061100841T CY1105398T1 (el) 1997-08-01 2006-06-21 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
CY20061101369T CY1105240T1 (el) 1997-08-01 2006-09-21 5’ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20061100841T CY1105398T1 (el) 1997-08-01 2006-06-21 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ

Country Status (11)

Country Link
EP (2) EP1375514B1 (el)
JP (1) JP2002525024A (el)
AT (2) ATE328078T1 (el)
AU (1) AU8555698A (el)
CA (1) CA2296844A1 (el)
CY (2) CY1105398T1 (el)
DE (2) DE69835777T2 (el)
DK (2) DK1375514T3 (el)
ES (2) ES2266693T3 (el)
PT (2) PT1375514E (el)
WO (1) WO1999006553A2 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372473B1 (en) 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
CA2297157A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in testis and other tissues
IL121860A0 (en) 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US7704944B2 (en) 1997-08-14 2010-04-27 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
US7220717B2 (en) 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
US6392019B1 (en) 1997-11-22 2002-05-21 John Ford Antibodies specific for EGF motif proteins
US6808890B2 (en) 1999-07-28 2004-10-26 Nuvelo, Inc. Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
CA2309897A1 (en) 1997-11-22 1999-06-03 Hyseq, Inc. A novel egf motif protein obtained from a cdna library of fetal liver-spleen
KR100386046B1 (ko) * 1997-12-03 2003-06-02 제넨테크, 인크. 폴리펩티드 및 이를 암호화하는 핵산
ES2222959T3 (es) * 1997-12-11 2005-02-16 Genentech, Inc. Polipeptidos pro241 y acido nucleico codificante de los mismos.
WO1999067387A2 (en) * 1998-06-25 1999-12-29 Millennium Pharmaceuticals, Inc. Novel mp-7 protein and nucleic acid molecules and uses therefor
AU2596700A (en) * 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
FR2796652B1 (fr) * 1999-07-20 2003-03-21 Inst Nat Sante Rech Med Acides nucleiques codant pour des peptides possedant l'activite biologique de la sorbine
US20020004236A1 (en) * 2000-04-25 2002-01-10 Meyers Rachel A. 27960, a novel ubiquitin conjugating enzyme family member and uses therefor
US6979551B2 (en) 2000-04-03 2005-12-27 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US6740495B1 (en) 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7109302B1 (en) 2002-04-01 2006-09-19 Human Genome Sciences, Inc. Antibodies that specifically bind to GMAD
JP6455983B2 (ja) * 2013-10-25 2019-01-23 国立大学法人神戸大学 アミロイド分解能を有する人工ペプチドおよびその利用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0832981A1 (en) * 1987-02-17 1998-04-01 Pharming B.V. DNA sequences to target proteins to the mammary gland for efficient secretion
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) * 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
CA2297157A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in testis and other tissues

Also Published As

Publication number Publication date
ES2260841T3 (es) 2006-11-01
EP1000151A2 (en) 2000-05-17
EP1375514B1 (en) 2006-08-30
ES2266693T3 (es) 2007-03-01
AU8555698A (en) 1999-02-22
DE69835777T2 (de) 2007-09-06
PT1375514E (pt) 2006-10-31
EP1375514A3 (en) 2004-05-19
DE69834727D1 (de) 2006-07-06
PT1000151E (pt) 2006-07-31
DE69834727T2 (de) 2007-01-25
ATE328078T1 (de) 2006-06-15
CY1105398T1 (el) 2010-04-28
WO1999006553B1 (en) 1999-05-27
EP1375514A2 (en) 2004-01-02
DK1000151T3 (da) 2006-10-02
DK1375514T3 (da) 2007-01-08
CA2296844A1 (en) 1999-02-11
WO1999006553A3 (en) 1999-04-08
JP2002525024A (ja) 2002-08-13
WO1999006553A2 (en) 1999-02-11
ATE338064T1 (de) 2006-09-15
DE69835777D1 (de) 2006-10-12
EP1000151B1 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
CY1105240T1 (el) 5’ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
DK1378571T3 (da) 5' ESTs for sekreterede proteiner udtrykt i forskellige væv
WO1999006550A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
ATE361933T1 (de) 5' ests für sekretierte proteine aus gehirngeweben
ATE323161T1 (de) 5' ests für sekretierte proteine die im gehirn expremiert werden
WO1999053051A3 (en) 5' ests and encoded human proteins
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
EP1439230A3 (en) Human transmembrane protein TMP-2 gene
ATE529444T1 (de) Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
DE69731834D1 (de) Agouti verwandtes gen
DE69637648D1 (de) Verfahren zur herstellung rekombinanter adenovirus-genome
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
WO2000008157A3 (en) Human anion transporter genes atnov
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
BG102878A (en) The use of genetic change in the gene of the human g-protein, 3-subunit for the diagnostics of diseases
ATE207536T1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
WO2000058464A3 (en) Rab genes and their uses
WO2003052377A9 (en) 41 human secreted proteins
DE69733320D1 (de) Differenzierungsfaktor der hypophyse und methoden zu seiner verwendung.
AU7433696A (en) Tyrosine kinase associated protein-1 (tka-1), nucleotide and amino acid sequences and their use in diagnosis and treatment of tka-1 related disorders